Advanced Heart Failure and Transplant Cardiology · Indianapolis, IN
NPI
1710205984
Since 2010
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
8333 Naab Rd Ste 420
Indianapolis, IN, 46260
Phone (317) 338-6666
Groups this clinician bills Medicare through
Medicare paid, 2024
$69K
1,092 services
Medicare patients, 2024
371
Average age 74
Drug cost, 2024
$8.4M
4,021 prescriptions
Company payments, 2025
$25K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amit C Patel was code 99214 (office e&m - established), 144 times for 103 patients. In total Amit C Patel billed 1,092 services in 54 codes, and Medicare paid $69K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 144 | 103 | $83.53 | $12K |
| 93306 Echocardiography (TTE/TEE) | Facility | 126 | 126 | $44.76 | $5,640 |
| 93750 External Electrocardiographic Monitoring | Facility | 103 | 29 | $28.16 | $2,900 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 96 | 76 | $12.10 | $1,162 |
| 99291 Critical Care E&M | Facility | 86 | 19 | $152.13 | $13K |
| 99233 Hospital E&M - Subsequent | Facility | 62 | 28 | $84.23 | $5,222 |
| 99215 Office E&M - Established | Office | 57 | 40 | $119.43 | $6,808 |
| 99152 Anesthesia | Facility | 47 | 44 | $8.80 | $414 |
| 93451 Percutaneous Transcatheterization | Facility | 42 | 38 | $82.74 | $3,475 |
| 93000 Electrocardiogram | Office | 32 | 31 | $9.49 | $304 |
| 99205 Office E&M - New | Office | 21 | 21 | $154.65 | $3,248 |
| 93320 Echocardiography (TTE/TEE) | Facility | 18 | 18 | $12.40 | $223 |
| 99451 E&M - Miscellaneous | Office | 14 | 13 | $23.97 | $336 |
| 93312 Echocardiography (TTE/TEE) | Facility | 14 | 14 | $72.72 | $1,018 |
| 93325 Echocardiography (TTE/TEE) | Facility | 13 | 13 | $2.12 | $27.51 |
By year: 2022 $61K for 954 services; 2023 $69K for 986 services; 2024 $69K for 1,092 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amit C Patel prescribed most often to Medicare patients was Spironolactone, with 306 prescriptions and refills. In total Amit C Patel wrote 4,021 Medicare prescriptions that cost $8.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Spironolactone Generic | 306 | 831 | 95 | $2,173 |
| Entresto Sacubitril/Valsartan | 253 | 528 | 70 | $331K |
| Atorvastatin Calcium Generic | 246 | 689 | 76 | $1,680 |
| Metoprolol Succinate Generic | 200 | 541 | 67 | $2,496 |
| Vyndamax Tafamidis | 188 | 194 | 19 | $4.5M |
| Ezetimibe Generic | 175 | 439 | 43 | $2,220 |
| Jardiance Empagliflozin | 169 | 414 | 54 | $236K |
| Torsemide Generic | 165 | 464 | 62 | $4,952 |
| Farxiga Dapagliflozin Propanediol | 156 | 293 | 37 | $164K |
| Eliquis Apixaban | 141 | 313 | 37 | $173K |
| Warfarin Sodium Generic | 105 | 308 | 24 | $1,950 |
| Losartan Potassium Generic | 98 | 261 | 25 | $896 |
| Mounjaro Tirzepatide | 85 | 97 | 15 | $102K |
| Repatha Sureclick Evolocumab | 85 | 177 | 25 | $101K |
| Furosemide Generic | 81 | 192 | 33 | $270 |
Brand drugs: - claims; generic drugs: 2,626 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amit C Patel $25K ($25K in general payments such as food, travel and fees) from 6 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $15K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.